Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2009
10/01/2009WO2009120699A2 Antimicrobials having polyquarternary ammoniums and alcohol-bearing amidoamines and methods for their use
10/01/2009WO2009120697A2 Method and compositions for treatment of cancer
10/01/2009WO2009120656A1 Pharmaceutical for ocular indications
10/01/2009WO2009120650A1 Aromatic heterocyclic fused indolobenzadiazepine hcv ns5b inhibitors
10/01/2009WO2009120648A1 Selective subtype alpha 2 adrenergic agents and methods for use thereof
10/01/2009WO2009120615A2 Substituted gamma lactams as therapeutic agents
10/01/2009WO2009120580A2 Methods for preventing or treating bruxism using dopaminergic
10/01/2009WO2009120565A2 Novel prodrugs of c-17-heteroaryl steroidal cyp17 inhibitors/antiandrogens: synthesis, in vitro biological activities, pharmacokinetics and antitumor activity
10/01/2009WO2009120493A2 Stabilized compositions of alkylating agents and methods of using same
10/01/2009WO2009120413A2 Preventing or reducing risk of miscarriages
10/01/2009WO2009120390A2 Cyclopropanated carbohydrates
10/01/2009WO2009120389A1 Oral and injectable formulations of tetracycline compounds
10/01/2009WO2009120371A2 Computationally designed inhibitors of amyloidosis
10/01/2009WO2009120296A1 Treatment of psoriasis or psoriatic arthritis using cyclopropyl-n-{2-{(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide
10/01/2009WO2009120277A1 Use and composition for treating dementia
10/01/2009WO2009120244A1 Image-guided therapy of myocardial disease: composition, manufacturing and applications
10/01/2009WO2009120214A1 Compositions comprising anrnox-inhibitors for the inhibition of reactive oxygen species
10/01/2009WO2009120192A2 Process for the preparation of benzo-fused heteroaryl derivatives
10/01/2009WO2009120191A1 Process for the preparation of benzo-fused heteroaryl sulfamates and crystalline form of n- ( ( (2s) -6-chloro-2,3-dihydro-l,4-benzodioxin-2-yl) methyl-sulfamide
10/01/2009WO2009120189A1 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of anxiety
10/01/2009WO2009120167A1 Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
10/01/2009WO2009120162A1 'ua' orion ' substance
10/01/2009WO2009120140A1 Novel 5,7-disubstituted [1,3]thiazolo[4,5-d]pyrimidin-2(3h)-one derivatives 258
10/01/2009WO2009120094A2 Substituted pyrimidines and triazines and their use in cancer therapy
10/01/2009WO2009120080A1 Chewing gum compositions comprising cannabinoids
10/01/2009WO2009120054A1 24-hour sustained-release metoclopramide
10/01/2009WO2009120053A1 12-hour sustained-release metoclopramide
10/01/2009WO2009120052A1 Pharmaceutical composition having a synergistic effect, for the treatment of high blood pressure and dyslipidemia
10/01/2009WO2009120002A2 Percutaneous preparation containing donepezil as active ingredient for treatment of dementia
10/01/2009WO2009119987A2 Composition comprising pyrazole derivatives for preventing or treating osteoporosis
10/01/2009WO2009119982A2 Adamantine derivative for inhibiting toxicity of amyloid oligomer
10/01/2009WO2009119935A1 Method and composition for inducing regeneration of damaged cartilage using microfracture and hyaluronic acid
10/01/2009WO2009119880A1 Substituted pyrazole derivatives and use thereof
10/01/2009WO2009119858A1 Benzene compound, and use thereof for medical purposes
10/01/2009WO2009119836A1 Composition for external application comprising transcription factor decoy as active ingredient
10/01/2009WO2009119794A1 Prophylactic/therapeutic agent for infectious disease
10/01/2009WO2009119785A1 Method for purifying ethynylthymidine compound
10/01/2009WO2009119776A1 Fused heterocyclic derivative and use thereof
10/01/2009WO2009119726A1 Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor
10/01/2009WO2009119710A1 Novel antibiotic sf2896 substance, process for production thereof, and pharmaceutical composition
10/01/2009WO2009119692A1 Novel glycolipid and use thereof
10/01/2009WO2009119673A1 Transdermally absorbable preparation
10/01/2009WO2009119672A1 COMPOSITION FOR STABILIZING β-BLOCKER, AND TRANSDERMALLY ABSORBABLE PREPARATION COMPRISING THE COMPOSITION
10/01/2009WO2009119667A1 Helicobacter pylori GROWTH INHIBITOR AND METHOD FOR PRODUCTION THEREOF
10/01/2009WO2009119652A1 USE OF BENZOPHENONE DERIVATIVE OR SALT THEREOF AND TNF α INHIBITOR IN COMBINATION AND PHARMACEUTICAL COMPOSITION CONTAINING THE DERIVATIVE OR SALT THEREOF AND THE INHIBITOR
10/01/2009WO2009119601A1 Water-based adhesive skin patch comprising ketoprofen lysine salt
10/01/2009WO2009119554A1 Promoter for bicarbonate secretion in gastrointestinal tract
10/01/2009WO2009119537A1 Hydroxyquinoxalinecarboxamide derivative
10/01/2009WO2009119534A1 Novel tetrahydroisoquinoline derivative
10/01/2009WO2009119528A1 Heterocyclic compound
10/01/2009WO2009119167A1 Aniline derivative having anti-rna viral activity
10/01/2009WO2009119099A1 Skin circulation-improving agent and skin temperature-elevating agent
10/01/2009WO2009119092A1 Anti-tumor agent comprising cytidine derivative and carboplatin
10/01/2009WO2009119088A1 Heterocyclic compound
10/01/2009WO2009118974A1 Administration method proposing device
10/01/2009WO2009118968A1 Satiety sensation-inducing agent and food or drink containing the same
10/01/2009WO2009118764A1 Pharmaceutical composition comprising diclofenac and paracetamol
10/01/2009WO2009118759A2 Heterocyclic compounds as adenosine receptor antagonist
10/01/2009WO2009118758A2 Novel crystalline forms of desvenlafaxine succinate
10/01/2009WO2009118756A2 Delayed release compositions of duloxetine
10/01/2009WO2009118753A2 Process for preparation of naratriptan hydrochloride
10/01/2009WO2009118749A1 Benzophenone-piperazine linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids as potential anticancer agents and process for the preparation thereof
10/01/2009WO2009118748A1 Isoxazoline linked pyrrolo[2,1-c[1,4]benzodiazepine hybrids as potential anticancer agents and the process for preparation thereof
10/01/2009WO2009118747A1 Novel hydroxy functionalized 1, 2, 4-trioxanes as antimalarial agents and a process for the preparation thereof
10/01/2009WO2009118726A2 Oral combination of vitamins
10/01/2009WO2009118680A1 Process for the preparation of sterile doripenem
10/01/2009WO2009118657A2 Polymorphic form of an aminoindan mesylate derivative
10/01/2009WO2009118655A2 Highly pure paliperidone or a pharmaceutically acceptable salt thereof substantially free of keto impurity
10/01/2009WO2009118589A2 Orally disintegrating compositions of rhein or diacerein
10/01/2009WO2009118567A2 Pyrimidines, triazines and their use as pharmaceutical agents
10/01/2009WO2009118562A1 Pharmaceutical composition 271
10/01/2009WO2009118560A1 Combination therapy 038
10/01/2009WO2009118541A1 Modulation of fibroblast activity
10/01/2009WO2009118523A1 Adjuvant
10/01/2009WO2009118516A1 Process for the preparation of donepezil hydrochloride
10/01/2009WO2009118493A2 Method for the continuous synthesis of an n-acylated compound, and equipment for implementing said method
10/01/2009WO2009118475A2 Platinum-n-heterocyclic carbene derivatives, preparation thereof and therapeutic use thereof
10/01/2009WO2009118473A2 Azetidine-derived compounds, preparation method therefor and therapeutic use of same
10/01/2009WO2009118443A1 Oviedomycin derivatives, method for obtaining same and use thereof
10/01/2009WO2009118441A1 Use of pentacyclic triterpene for the preparation of a pharmaceutical compound intended for the treatment of multiple sclerosis
10/01/2009WO2009118384A1 Quinazolinone derivatives as tubulin polymerization inhibitors
10/01/2009WO2009118382A1 Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as parp and tubulin polymerization inhibitors
10/01/2009WO2009118380A1 Use of oleuropein and derivatives in the treatment of type 2 diabetes mellitus and pathologies associated with protein aggregation phenomena
10/01/2009WO2009118379A1 An antimicrobial composition
10/01/2009WO2009118371A1 Use of nicotinamide for treating summer itch in horses
10/01/2009WO2009118370A1 Aza-bicyclohexyl substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
10/01/2009WO2009118359A2 Capsule for the prevention of cardiovascular diseases
10/01/2009WO2009118338A2 Use of a polyphenolic type compound for preventing or treating a polyglutamine expansion neurodegenerative disease
10/01/2009WO2009118327A1 1,4-naphthoquinone derivatives and therapeutic use thereof
10/01/2009WO2009118324A1 5imidazoquinolines and pyrimidine derivatives as potent modulators of vegf-driven angiogenic processes
10/01/2009WO2009118322A1 Process for preparing orally administered dabigatran formulations
10/01/2009WO2009118321A1 Method for manufacturing acid pellets
10/01/2009WO2009118305A1 Hydroxamate-based inhibitors of deacetylases b
10/01/2009WO2009118296A2 Novel substituted imidazoquinolines
10/01/2009WO2009118292A1 Arylsulfonamide-based matrix metalloprotease inhibitors
10/01/2009WO2009118259A1 Ptph1 inhibitors for the treatment of alzheimer's disease
10/01/2009WO2009118254A1 Aminopiperidinyl derivatives and uses thereof
10/01/2009WO2009118191A2 Therapy for vitiligo
10/01/2009WO2009118187A1 Methods for treating disorders using nmda nr2b-subtype selective antagonist
10/01/2009WO2009118175A1 Novel p2x7r antagonists and their use
1 ... 2551 2552 2553 2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 2569 2570 2571 ... 7860